ConductScience.org, home

Paper25225409

Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer.

Läubli H and 13 others. Proc Natl Acad Sci U S A, 2014. Cited by 201 papers, by iCite.

Cite this record

ConductScience Library. Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer. Papers, record 25225409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25225409

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
2014
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
201
iCite
Relative citation ratio, by iCite
5.14
iCite
Revised in PubMed
2025-05-29
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Läubli HHeinz
2Pearce OMOliver M T
3Schwarz FFlavio
4Siddiqui SSShoib S
5Deng LLingquan
6Stanczak MAMichal A
7Deng LLiwen
8Verhagen AAndrea
9Secrest PPatrick
10Lusk CChrissy
11Schwartz AGAnn G
12Varki NMNissi M
13Bui JDJack D
14Varki AAjit

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, CDMajor topic
Antigens, Differentiation, B-LymphocyteMajor topic
Immunity, InnateMajor topic
NeoplasmsMajor topic
Sialic Acid Binding Immunoglobulin-like LectinsMajor topic
Animals
Carcinoma, Non-Small-Cell Lung
Cell Line, Tumor
Female
Humans
Ligands
Lung Neoplasms
Male
Mice
Mice, Knockout
Mice, Transgenic
Monocytes
Neutrophil Activation
Polymorphism, Single Nucleotide
Tumor Microenvironment

Source PubMed

Download CSV of topics

Grants9

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01CA14176NCI NIH HHSUnited StatesPubMedPubMed
R01CA38701NCI NIH HHSUnited StatesR01CA038701PubMed and NIHNIH RePORTER
R01 CA141769NCI NIH HHSUnited StatesR01CA141769PubMed and NIHNIH RePORTER
R01060691PHS HHSUnited StatesPubMedPubMed
P30CA022453NCI NIH HHSUnited StatesP30CA022453PubMed and NIHNIH RePORTER
N01 PC035145NCI NIH HHSUnited StatesN01PC035145PubMedNIH RePORTER
P30 CA023100NCI NIH HHSUnited StatesP30CA023100PubMed and NIHNIH RePORTER
R01 CA038701NCI NIH HHSUnited StatesR01CA038701PubMed and NIHNIH RePORTER
P30 CA022453NCI NIH HHSUnited StatesP30CA022453PubMed and NIHNIH RePORTER

Download CSV of grants

References46

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115342420Expression of complement factor H by lung cancer cells: effects on the activation of the alternative pathway of complement.Cancer Res2004https://conductscience.org/library/papers/15342420PubMed
223329041Neutralizing tumor-promoting chronic inflammation: a magic bullet?Science2013https://conductscience.org/library/papers/23329041PubMed
369628Selective radioactive labeling of cell surface sialoglycoproteins by periodate-tritiated borohydride.J Biol Chem1977https://conductscience.org/library/papers/69628PubMed
416682635Loss of Siglec expression on T lymphocytes during human evolution.Proc Natl Acad Sci U S A2006https://conductscience.org/library/papers/16682635PubMed
515292262Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9.J Biol Chem2004https://conductscience.org/library/papers/15292262PubMed
619178537Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors.Clin Exp Allergy2009https://conductscience.org/library/papers/19178537PubMed
724154716Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms.Nat Rev Cancer2013https://conductscience.org/library/papers/24154716PubMed
822444630Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer.Immunity2012https://conductscience.org/library/papers/22444630PubMed
924045940Binding of the sialic acid-binding lectin, Siglec-9, to the membrane mucin, MUC1, induces recruitment of β-catenin and subsequent cell growth.J Biol Chem2013https://conductscience.org/library/papers/24045940PubMed
1014708027Tumour-educated macrophages promote tumour progression and metastasis.Nat Rev Cancer2004https://conductscience.org/library/papers/14708027PubMed
1121436444Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.Science2011https://conductscience.org/library/papers/21436444PubMed
1220956342Sialylation of 3-methylcholanthrene-induced fibrosarcoma determines antitumor immune responses during immunoediting.J Immunol2010https://conductscience.org/library/papers/20956342PubMed
1310801860Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways.J Biol Chem2000https://conductscience.org/library/papers/10801860PubMed
1410764831Siglec-7: a sialic acid-binding lectin of the immunoglobulin superfamily.Glycobiology2000https://conductscience.org/library/papers/10764831PubMed
1519076345Basic and clinical immunology of Siglecs.Ann N Y Acad Sci2008https://conductscience.org/library/papers/19076345PubMed
1623029261Engagement of Siglec-7 receptor induces a pro-inflammatory response selectively in monocytes.PLoS One2012https://conductscience.org/library/papers/23029261PubMed
1722467657Colonic epithelial cells express specific ligands for mucosal macrophage immunosuppressive receptors siglec-7 and -9.J Immunol2012https://conductscience.org/library/papers/22467657PubMed
1823485549Modulation of neutrophil granulocytes in the tumor microenvironment: mechanisms and consequences for tumor progression.Semin Cancer Biol2013https://conductscience.org/library/papers/23485549PubMed
1920733319A novel function of Siglec-9 A391C polymorphism on T cell receptor signaling.Int Arch Allergy Immunol2011https://conductscience.org/library/papers/20733319PubMed
2024145038Binding of a sialic acid-recognizing lectin Siglec-9 modulates adhesion dynamics of cancer cells via calpain-mediated protein degradation.J Biol Chem2013https://conductscience.org/library/papers/24145038PubMed

See all 46 referencesDownload CSV of references

Cited by140

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 201 citations.

PMIDTitleJournalYearIn PapersSource
42919624Siglec-15 and its glycan ligands in tumor-associated macrophage biology and immunotherapy.J Immunother Cancer2026https://conductscience.org/library/papers/42919624PubMed
42427411Sialic acid-modified phosphorene for low-necrosis and targeted drug delivery in breast cancer.RSC Adv2026https://conductscience.org/library/papers/42427411PubMed
42277951Roles of neutrophil extracellular traps in cancer immunotherapy resistance and therapeutic targeting.Biomark Res2026https://conductscience.org/library/papers/42277951PubMed
42153609Sialylation in Colorectal Cancer Rewires Antitumor Immunity at the Peritoneal Metastatic Site.Eur J Immunol2026https://conductscience.org/library/papers/42153609PubMed
41402487Antibody-lectin chimeras for glyco-immune checkpoint blockade.Nat Biotechnol2026https://conductscience.org/library/papers/41402487PubMed
41398201Siglec-14-LGALS3BP glycoimmune axis shapes tumor-associated macrophage polarization and confers poor outcome in colorectal cancer.NPJ Precis Oncol2025https://conductscience.org/library/papers/41398201PubMed
41390763HIV-induced sialoglycans on infected CD4+ T cells promote immune evasion from myeloid cell-mediated killing.Nat Commun2025https://conductscience.org/library/papers/41390763PubMed
41311955Molecular Insights into the Engagement of High-Affinity Sialylated Ligands to Human CD22.JACS Au2025https://conductscience.org/library/papers/41311955PubMed
41303731Decoding SIGLEC12 in Bladder Cancer: In Silico Profiling of Expression, Tumor-Immune Interactions, and Prognostic Impact.Medicina (Kaunas)2025https://conductscience.org/library/papers/41303731PubMed
41215973Increase of Inhibitory Siglec receptors on T cells mitigates severe immune reactions during acute viral infections.PNAS Nexus2025https://conductscience.org/library/papers/41215973PubMed
41154604Dysregulated Sialylation in Cancer: From Immunosuppressive Microenvironment to Siglec-Targeted Therapeutics.Biomolecules2025https://conductscience.org/library/papers/41154604PubMed
40892920Tumor-expressed GPNMB orchestrates Siglec-9+ TAM polarization and EMT to promote metastasis in triple-negative breast cancer.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/40892920PubMed
40874587Targeting Myeloid Cells for Cancer Immunotherapy.Cancer Immunol Res2025https://conductscience.org/library/papers/40874587PubMed
40533266Tumor glyco-immunology, glyco-immune checkpoints and immunotherapy.J Immunother Cancer2025https://conductscience.org/library/papers/40533266PubMed
40500109IL-4-STAT6-induced high Siglec-G/10 expression aggravates the severe immune suppressive tumor microenvironment and impedes the efficacy of immunotherapy in head and neck squamous cell carcinoma.J Immunother Cancer2025https://conductscience.org/library/papers/40500109PubMed
40333992The inhibitory receptor Siglec-E controls antigen-presenting cell activation and T cell-mediated transplant rejection.Sci Transl Med2025https://conductscience.org/library/papers/40333992PubMed
40191202Targeting tumor-associated macrophages in colon cancer: mechanisms and therapeutic strategies.Front Immunol2025https://conductscience.org/library/papers/40191202PubMed
40076855Insights on the Role of Sialic Acids in Acute Lymphoblastic Leukemia in Children.Int J Mol Sci2025https://conductscience.org/library/papers/40076855PubMed
39813162Proximity Labeling and Genetic Screening Reveal that DSG2 is a Counter Receptor of Siglec-9 and Suppresses Macrophage Phagocytosis.Adv Sci (Weinh)2025https://conductscience.org/library/papers/39813162PubMed
39755580Targeting Siglec-E facilitates tumor vaccine-induced antitumor immunity in renal carcinoma.J Immunother Cancer2025https://conductscience.org/library/papers/39755580PubMed

See all 140 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
SIGLEC927180PubTator's text mininghttps://conductscience.org/library/genes/27180

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25225409

GET https://conductscience.org/api/papers/v1/25225409/references?page=2